Previous studies show that ADAM10 levels and activity in neurons is significantly reduced in AD patients in comparison to age-matched controls [46–48] and that the presence of ApoE4 reduces ADAM10 activity levels in comparison to other ApoE isoforms [49]. The gene discussed is APOE; the disease is Alzheimer disease.